Acorda Therapeutics Inc (NASDAQ:ACOR) shares are dropping like a hot potato down 25% to the market floor after the biotech firm revealed it was hit with refusal to file (RTF) letter from the FDA ...

If you are looking to invest in Acorda Therapeutics Inc’s (NASDAQ:ACOR), or currently own the stock, then you need to understand its beta in order to understand how it can affect the risk of your ...

May 22—ALMEDIA — Matt Acor was sidelined last season by a torn elbow ligament, so his four-RBI game in Danville's season opener was a triumphant return to varsity baseball. Turns out, it was just the ...

Nasdaq Analyst Research provides analyst research for ratings consensus and a summary of stock price targets. Analysts evaluate the stock’s expected performance in a given time period based on their ...

The Medical group has plenty of great stocks, but investors should always be looking for companies that are outperforming their peers. Acorda Therapeutics (ACOR) is a stock that can certainly grab the ...

Looking for a stock that might be in a good position to beat earnings at its next report? Consider Acorda Therapeutics, Inc. ( ACOR), a firm in the Medical-Biomedical industry, which could be a great ...